1. Home
  2. ABSI vs GDRX Comparison

ABSI vs GDRX Comparison

Compare ABSI & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Absci Corporation

ABSI

Absci Corporation

N/A

Current Price

$7.14

Market Cap

997.8M

Sector

Health Care

ML Signal

N/A

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

N/A

Current Price

$3.11

Market Cap

1.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ABSI
GDRX
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
997.8M
1.0B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ABSI
GDRX
Price
$7.14
$3.11
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$6.96
$3.66
AVG Volume (30 Days)
4.0M
942.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
10.64
125.00
EPS
N/A
N/A
Revenue
$4,534,000.00
$796,853,000.00
Revenue This Year
$215.96
N/A
Revenue Next Year
$319.10
$5.38
P/E Ratio
N/A
$28.94
Revenue Growth
N/A
0.57
52 Week Low
$2.24
$1.77
52 Week High
$12.06
$5.61

Technical Indicators

Market Signals
Indicator
ABSI
GDRX
Relative Strength Index (RSI) 34.84 60.21
Support Level $2.56 $2.47
Resistance Level $12.06 $3.16
Average True Range (ATR) 0.71 0.12
MACD -0.44 -0.01
Stochastic Oscillator 5.44 75.64

Price Performance

Historical Comparison
ABSI
GDRX

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Share on Social Networks: